Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2010 (2010), Article ID 876701, 11 pages
http://dx.doi.org/10.1155/2010/876701
Research Article

Deletion of the Men1 Gene Prevents Streptozotocin-Induced Hyperglycemia in Mice

1Abramson Family Cancer Research Institute, Department of Cancer Biology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA
2Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Philadelphia, PA 19104, USA

Received 16 September 2010; Revised 9 November 2010; Accepted 3 December 2010

Academic Editor: Anjan Kowluru

Copyright © 2010 Yuqing Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Bluestone, K. Herold, and G. Eisenbarth, “Genetics, pathogenesis and clinical interventions in type 1 diabetes,” Nature, vol. 464, no. 7293, pp. 1293–1300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Stumvoll, B. J. Goldstein, and T. W. van Haeften, “Type 2 diabetes: pathogenesis and treatment,” The Lancet, vol. 371, no. 9631, pp. 2153–2156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Stumvoll, B. J. Goldstein, and T. W. van Haeften, “Pathogenesis of type 2 diabetes,” Endocrine Research, vol. 32, no. 1-2, pp. 19–37, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Atkinson and G. S. Eisenbarth, “Type 1 diabetes: new perspectives on disease pathogenesis and treatment,” The Lancet, vol. 358, no. 9277, pp. 221–229, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Parker, S. Xue, J. J. Alexander et al., “Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice,” Diabetes, vol. 58, no. 10, pp. 2277–2284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Begum, W. Chen, K. C. Herold, and V. E. Papaioannou, “Remission of type 1 diabetes after anti-CD3 antibody treatment and transplantation of embryonic pancreatic precursors,” Endocrinology, vol. 150, no. 10, pp. 4512–4520, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. R. Saltiel and J. M. Olefsky, “Thiazolidinediones in the treatment of insulin resistance and type II diabetes,” Diabetes, vol. 45, no. 12, pp. 1661–1669, 1996. View at Google Scholar · View at Scopus
  8. J. M. Olefsky, “Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 467–472, 2000. View at Google Scholar · View at Scopus
  9. K. Robertson, Y. Lu, K. De Jesus et al., “A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes,” American Journal of Physiology, vol. 294, no. 5, pp. E928–E938, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Uchida, T. Nakamura, N. Hashimoto et al., “Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice,” Nature Medicine, vol. 11, no. 2, pp. 175–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Fu, A. C. H. Ng, C. Depatie et al., “Loss of Lkb1 in adult β cells increases β cell mass and enhances glucose tolerance in mice,” Cell Metabolism, vol. 10, no. 4, pp. 285–295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. F. C. Tanner, M. Boehm, L. M. Akyürek et al., “Differential effects of the cyclin-dependent kinase inhibitors p27Kip1, p21Cip1 and p16Ink4 on vascular smooth muscle cell proliferation,” Circulation, vol. 101, no. 17, pp. 2022–2025, 2000. View at Google Scholar · View at Scopus
  13. A. S. Green, N. Chapuis, T. T. Maciel et al., “The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation,” Blood, vol. 116, no. 20, pp. 4262–4273, 2010. View at Publisher · View at Google Scholar
  14. S. J. Marx and C. A. Stratakis, “Multiple endocrine neoplasia—introduction,” Journal of Internal Medicine, vol. 257, no. 1, pp. 2–5, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. S. Crabtree, P. C. Scacheri, J. M. Ward et al., “Of mice and MEN1: insulinomas in a conditional mouse knockout,” Molecular and Cellular Biology, vol. 23, no. 17, pp. 6075–6085, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. P. C. Scacheri, J. S. Crabtree, A. L. Kennedy et al., “Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1,” Mammalian Genome, vol. 15, no. 11, pp. 872–877, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. S. Crabtree, P. C. Scacheri, J. M. Ward et al., “A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 3, pp. 1118–1123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. R. W. Schnepp, Y. X. Chen, H. Wang et al., “Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells,” Cancer Research, vol. 66, no. 11, pp. 5707–5715, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. R. C. McEvoy, J. Andersson, S. Sandler, and C. Hellerstrom, “Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line,” Journal of Clinical Investigation, vol. 74, no. 3, pp. 715–722, 1984. View at Google Scholar · View at Scopus
  20. S. Lenzen, “The mechanisms of alloxan- and streptozotocin-induced diabetes,” Diabetologia, vol. 51, no. 2, pp. 216–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Nakamura, S. Nagafuchi, K. Yamaguchi, and R. Takaki, “The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice,” Diabetes, vol. 33, no. 9, pp. 894–900, 1984. View at Google Scholar · View at Scopus
  22. N. Liadis, K. Murakami, M. Eweida et al., “Caspase-3-dependent β-cell apoptosis in the initiation of autoimmune diabetes mellitus,” Molecular and Cellular Biology, vol. 25, no. 9, pp. 3620–3629, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. J. Reed, K. Meszaros, L. J. Entes et al., “A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat,” Metabolism, vol. 49, no. 11, pp. 1390–1394, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Lois, E. J. Hong, S. Pease, E. J. Brown, and D. Baltimore, “Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors,” Science, vol. 295, no. 5556, pp. 868–872, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Jin, H. Mao, R. W. Schnepp et al., “Menin associates with FANCD2, a protein involved in repair of DNA damage,” Cancer Research, vol. 63, no. 14, pp. 4204–4210, 2003. View at Google Scholar · View at Scopus
  26. S. L. Conarello, G. Jiang, J. Mu et al., “Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia,” Diabetologia, vol. 50, no. 1, pp. 142–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. D. G. Johnson, C. U. Goebel, and V. J. Hruby, “Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist,” Science, vol. 215, no. 4536, pp. 1115–1116, 1982. View at Google Scholar · View at Scopus
  28. J. Lu, P. L. Herrera, C. Carreira et al., “α cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development,” Gastroenterology, vol. 138, no. 5, pp. 1954–e8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Thorel, V. Népote, I. Avril et al., “Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss,” Nature, vol. 464, no. 7292, pp. 1149–1154, 2010. View at Publisher · View at Google Scholar
  30. J. A. Kushner, J. Ye, M. Schubert et al., “Pdx1 restores β cell function in Irs2 knockout mice,” Journal of Clinical Investigation, vol. 109, no. 9, pp. 1193–1201, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Oliver-Krasinski, M. T. Kasner, J. Yang et al., “The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice,” Journal of Clinical Investigation, vol. 119, no. 7, pp. 1888–1898, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Thorens, Y. J. Wu, J. L. Leahy, and G. C. Weir, “The loss of GLUT2 expression by glucose-unresponsive β cells of db/db mice is reversible and is induced by the diabetic environment,” Journal of Clinical Investigation, vol. 90, no. 1, pp. 77–85, 1992. View at Google Scholar · View at Scopus
  33. N. Gao, J. LeLay, M. Z. Vatamaniuk, S. Rieck, J. R. Friedman, and K. H. Kaestner, “Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development,” Genes and Development, vol. 22, no. 24, pp. 3435–3448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. M. Holland, L. J. Góñez, G. Naselli, R. J. MacDonald, and L. C. Harrison, “Conditional expression demonstrates the role of the homeodomain transcription factor Pdx1 in maintenance and regeneration of β-cells in the adult pancreas,” Diabetes, vol. 54, no. 9, pp. 2586–2595, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Inoue, J. H. Hager, N. Ferrara, H. P. Gerber, and D. Hanahan, “VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic β cell carcinogenesis,” Cancer Cell, vol. 1, no. 2, pp. 193–202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. I. Choudhury, H. Heffron, M. A. Smith et al., “The role of insulin receptor substrate 2 in hypothalamic and β cell function,” Journal of Clinical Investigation, vol. 115, no. 4, pp. 940–950, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. K. Karnik, H. Chen, G. W. McLean et al., “Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus,” Science, vol. 318, no. 5851, pp. 806–809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. S. J. Marx, “Molecular genetics of multiple endocrine neoplasia types 1 and 2,” Nature Reviews Cancer, vol. 5, no. 5, pp. 367–375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Bertolino, W. M. Tong, D. Galendo, Z. Q. Wang, and C. X. Zhang, “Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1,” Molecular Endocrinology, vol. 17, no. 9, pp. 1880–1892, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Busygina, M. C. Kottemann, K. L. Scott, S. E. Plon, and A. E. Bale, “Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response,” Cancer Research, vol. 66, no. 17, pp. 8397–8403, 2006. View at Publisher · View at Google Scholar